Showing results (71-80 of 135) with videos related to
Sort By:
Pageof 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
The Clinical Application of Fluorescence-Guided Surgery in Head and Neck CancerStan van Keulen, Naoki Nishio, Shayan Fakurnejad, et al.JAMA Dermatology|January 15, 2016
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell CarcinomaMina S Ally, Katherine Ransohoff, Kavita Sarin, et al.Cancer Chemotherapy and Pharmacology|September 13, 2015
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trialRobert J Morgan, Timothy W Synold, Jeffrey A Longmate, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failureEllen A Wiegner, Megan E Daly, James D Murphy, et al.Oral Oncology|January 9, 2019
Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinomaStan van Keulen, Nynke S van den Berg, Naoki Nishio, et al.Frontiers in Oncology|January 31, 2020
Intraoperative Molecular Imaging for <i>ex vivo</i> Assessment of Peripheral Margins in Oral Squamous Cell CarcinomaShayan Fakurnejad, Giri Krishnan, Stan van Keulen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase I and correlative biology study of cilengitide in patients with recurrent malignant gliomaL Burt Nabors, Tom Mikkelsen, Steven S Rosenfeld, et al.Cancer|August 24, 2005
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPhilip C Amrein, John R Clark, Jeffrey G Supko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agentMichelle A Rudek, Ming Zhao, Nicola F Smith, et al.Investigational New Drugs|November 27, 2007
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neckPatricia A Tang, Lillian L Siu, Eric X Chen, et al.Pageof 14